This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Forschungsverbund Berlin E.v.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Volker Haucke: Innovator in Phosphoinositide Research
Introduction
Volker Haucke is a prominent inventor based in Kleinmachnow, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target specific signaling pathways in the body. His work is crucial for advancing treatments for various medical conditions.
Latest Patents
Haucke holds a patent for "Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors." This patent describes compounds that can inhibit class II phosphoinositide 3-kinase (PI3K) signaling. These compounds are particularly useful for treating medical conditions associated with defective PI3K signaling, such as myopathy, cancer, diabetes, thrombosis, or cardiovascular disease. He has 1 patent to his name.
Career Highlights
Volker Haucke is affiliated with Forschungsverbund Berlin E.V., where he conducts his research. His work has been instrumental in understanding the role of PI3K signaling in various diseases, paving the way for innovative therapeutic approaches.
Collaborations
Haucke has collaborated with notable colleagues, including Wen-Ting Lo and Hassane Belabed. These partnerships have enhanced the scope and impact of his research.
Conclusion
Volker Haucke's innovative work in the field of phosphoinositide research highlights his commitment to advancing medical science. His contributions are vital for developing new treatments for serious health conditions.